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Abstract
An efficient strategy for the synthesis of 6-unsubstituted indolo[1,2-c]quinazolines is described. The Pd-catalyzed reaction of o-(o-
aminophenylethynyl) trifluoroacetanilides with Ar–B(OH)2 afforded 2-(o-aminophenyl)-3-arylindoles, that were converted to
12-arylindolo[1,2-c]quinazolines by adding dimethylformamide dimethyl acetal (DMFDMA) to the reaction mixture after extrac-
tive work-up. This reaction outcome is different from the previously reported Pd-catalyzed sequential reaction of the same sub-
strates with Ar–I, Ar–Br and ArN2+BF4−, that afforded 12-arylindolo[1,2-c]quinazolin-6(5H)-ones. Moreover, 12-unsubstituted
indolo[1,2-c]quinazolines can be obtained both by reacting 2-(o-aminophenyl)indoles with DMFDMA or by sequential Pd-cata-
lyzed reaction of o-(o-aminophenylethynyl)aniline with DMFDMA.
Introduction
Indoloquinazoline derivatives constitute an important class of
compounds which exhibit a wide range of biological activities
[1-4]. Then, extensive searches aimed at discovering pharmaco-
logically active compounds encouraged the synthesis of some
new products containing the indolequinazoline nucleus with the
aim to discover novel drug candidates [5-8]. In particular,
libraries of 6-substituted indolo[1,2-c]quinazolines were synthe-
sized and exhibited good antimicrobial as well as notable anti-
fungal activities [9-11]. Since the isolation of hinckdentine A,
an unusual marine alkaloid from the bryozoan Hincksinoflustra
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Scheme 1: Synthesis of 6-trifluoromethyl-12-aryl(vinyl)indolo[1,2-c]quinazolines 4.
Scheme 2: Present and previously reported reactions starting from 5. DMFDMA: dimethylformamide dimethyl acetal.
denticulata collected off the eastern coast of Tasmania [12,13],
indolo[1,2-c]quinazolines related to hinckdentine A received in-
creasing attention as a source of new and useful pharmaceuti-
cals. One well-established approach is based on the elaboration
of a preformed indole ring, for example through cyclocondensa-
tion of 2-(o-aminophenyl)indoles with 2-cyanobenzothiazoles
[14], aldehydes [9] and formic acid [15,16], or reactions of
2-(2-bromoaryl)-1H-indoles with aldehydes and aqueous
ammonia [17] or with amino acids [18]. An alternative ap-
proach to indoloquinazolines is represented by sequential proce-
dures that use 2-alkynylaniline derivatives as starting materials,
via their conversion to 2-(o-aminophenyl)indole derivatives fol-
lowed by further cyclization [19-22]. Our interest in this field
led to the development of an original approach to 6-trifluoro-
methyl-12-aryl(vinyl)indolo[1,2-c]quinazolines 4 through
sequential Pd-catalyzed reactions of bis(o-trifluoroacetamido-
phenyl)acetylene (1) with aryl or vinyl halides and triflates fol-
lowed by cyclization reactions (Scheme 1) [19].
The reaction, which tolerates a variety of important functional
groups, likely involves the formation of the indole intermedi-
ates 2 (through aminopalladation/reductive elimination) [20,21]
followed by cyclization to 3 and elimination of trifluoroacetic
acid (Scheme 1). Later, a procedure that allows the introduction
of a variety of substituents other than CF3 in the 6-position
(without the substituent in the 12-position) was reported by
Wang and co-workers [22]. More recently, we showed that the
Pd-catalyzed reaction of o-(o-aminophenylethynyl) trifluoro-
acetanilides 5 with aryl halides and aryldiazonium salts led to
the formation of 12-arylindolo[1,2-c]quinazolin-6(5H)-ones 8 in
moderate to excellent yields (Scheme 2a) [23]. Very likely,
under these reaction conditions, the palladium-catalyzed reac-
tion of 5 gave intermediates 6; then, cyclization to 7 followed
by elimination of trifluoromethane afforded products 8.
Since the unique molecular skeleton of hinckdentine A is
constituted of a 6-unsubstituted indolo[1,2-c]quinazoline
nucleus [12,13], we planned to modify our previous procedures
to address the 6-unsubstituted-12-arylindolo[1,2-c]quinazolines
10. We wish to report here that, under suitable reaction condi-
tions, substrates 5 can be easily converted into target products
10 (Scheme 2b). Moreover, 12-unsubstituted analogues 13 are
also available from 5 or from o-(o-aminophenylethynyl)anilines
15 (see below).
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Scheme 3: Two-step synthesis of 12-arylindolo[1,2-c]quinazoline 10a.
Results and Discussion
We have previously reported that arylboronic acids 12 can be
used in place of aryl halides in the Pd-catalyzed synthesis of
indoles through aminopalladation/reductive elimination reac-
tion from 2-alkynyltrifluoroacetanilides [24]. This reaction is
carried out in MeOH at 60 °C in the presence of K3PO4 under
an oxygen atmosphere. We then decided to react substrate 5
under these reaction conditions, in order to ascertain if the pres-
ence of methanol and base would result in the cleavage of the
trifluoroacetylamide group after the formation of the indole
ring, affording 2-(1H-indolo-2-yl)benzenamine derivatives 9
instead of products 8. We were pleased to observe the forma-
tion of 9a in good yields when 5 was reacted with 4-methoxy-
phenylboronic acid. A minor amount of product 11a (likely
deriving from a transamidation reaction [25] of initially formed
intermediate 6a) was also isolated. Then, 9a was treated with
dimethylformamide dimethyl acetal (DMFDMA) as a source of
an electrophilic one-carbon unit at the formate oxidation level
[26,27], affording 12-arylindolo[1,2-c]quinazoline 10a in good
yield (Scheme 3).
Based on this result, we tested an approach to target products 10
avoiding the isolation of intermediates 9. After some
experimentation, we found that the best results were obtained
from the following procedure: 1) Pd-catalyzed reaction of 5
with ArB(OH)2/K3PO4 in MeOH at 60 °C; 2) heating of the
reaction mixture at 100 °C to allow complete hydrolysis of by-
products 11; 3) after extractive work-up, treatment of the crude
reaction mixture with an excess of DMFDMA (5 equiv) [28] in
DMF at 100 °C to obtain indoloquinazolines 10. The results of
this procedure, starting from a variety of o-(o-aminophenyl-
ethynyl)trifluoroacetanilides 5 and arylboronic acids 12, are
summarized in Table 1.
In some cases, 12-unsubstituted indolo[1,2-c]quinazoline deriv-
atives 13 were also obtained as byproducts. Electron-rich aryl-
boronic acids worked quite well (Table 1, entries 1, 3, and 4).
However, an attempt to carry out the reaction under air, instead
of under O2 atmosphere, resulted in a loss of efficiency
(Table 1, entry 2). Good results were also observed with
phenyl- and 1-naphthylboronic acids (Table 1, entries 5 and 6).
Electron-poor arylboronic acids proved to be effective (Table 1,
entries 7–10), and only (4-chlorophenyl)boronic acid gave a
moderate yield of product (Table 1, entry 10).
Products substituted in the indole and quinazoline frameworks
were also obtained (Table 1, entries 12–16). It is worth noting
that the reaction tolerates a -Br substituent (Table 1, entries 8
and 16) which may serve as a useful handle for increasing mo-
lecular complexity through cross-coupling reactions. Only in
the case of two ortho-substituents on the aryl residue of the
boronic acid the reaction afforded the target product 10p in low
yield (Table 1, entry 17), and 12-unsubstituted derivative 13p as
the major product.
Then, with the aim of obtaining 12-unsubstituted indoloquina-
zolines 13 selectively, we tested the use of DMFDMA for the
cyclization of 2-(o-aminophenyl)indoles 14. This reaction re-
Beilstein J. Org. Chem. 2018, 14, 2411–2417.
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Table 1: Synthesis of 12-arylindolo[1,2-c]quinazolines 10.a
Entry R1 R2 5 Ar Time (h)b 10 (% yield)c 13 (% yield)c
1 H H 5a 4-MeO-C6H4- 3, 16, 16 10a (76) –
2 H H 5a 4-MeO-C6H4- 24, 18, 16 10a (49)d –
3 H H 5a 4-Me-C6H4- 5, 16, 16 10b (61) –
4 H H 5a 2-Me-C6H4- 5, 16, 16 10j (56) 13j (11)
5 H H 5a phenyl 24, 8, 12 10c (75) –
6 H H 5a 1-naphthyl 2, 16, 2 10d (60) –
7 H H 5a 4-CF3-C6H4- 4, 7, 16 10e (69) –
8 H H 5a 4-Br-C6H4- 2, 16, 6 10f (60) –
9 H H 5a 4-MeO2C-C6H4- 3, 28, 2 10g (59) –
10 H H 5a 4-Cl-C6H4- 6, 16, 3 10h (52) 13h (12)
11 H H 5a 18, 16, 2 10i (65) 13i (12)
12 Me H 5b 4-MeO-C6H4- 18, 6, 1 10k (63) 13k (5)
13 Me H 5b phenyl 24, 5, 4 10l (72) –
14 Me H 5b 1, 16, 8 10m (76) –
15 Me COOMe 5c 4-MeO-C6H4- 5, 16, 3 10n (60) –
16 H Me 5d 4-Br-C6H4- 6, 16, 1.5 10o (58) –
17 H H 5a 24, 24, 8 10p (12) 13p (38)
aReactions were carried out at 60 °C on 0.345 mmol scale using 1.0 equiv of 5, 2.0 equiv of 13, 0.05 equiv of Pd(OAc)2, 0.05 equiv of dppp and
2 equiv of K3PO4 in MeOH (2 mL) under an atmosphere of O2; then 100 °C; work-up; then 5 equiv of DMFDMA in DMF (2 mL), 100 °C. bNumbers
refer to the 1st, 2nd and 3rd step, respectively. cIsolated yields. dCarried out under air atmosphere.
quired only a slight excess of DMFDMA (1.2 equiv), and
afforded derivatives 13 as sole products in high yields
(Table 2).
As described in Supporting Information File 1, indoles 14a–c
(R1 = R3, R2 = H) were obtained by cyclization of the corre-
sponding o-(o-aminophenylethynyl)anilines 15a–c with
PdCl2(MeCN)2 [29,30]. Indoles 14d,e (R1 ≠ R3) could not be
obtained in such way (due to the lack of selectivity between the
two different NH2 groups in the hydroamination reaction), and
were obtained by cyclization of the corresponding o-(o-amino-
phenylethynyl) trifluoroacetanilides 5 with PdCl2(MeCN)2 (it
was previously demonstrated that the selective formation of 16
occurs under these conditions [31]) followed by the hydrolysis
of the COCF3 group of the crude product (Scheme 4).
Moreover, the palladium-catalyzed reaction of 15a in the pres-
ence of DMFDMA led directly to the formation of quinazoline
13a in 71% yield through a sequential process (Scheme 5a).
The selective formation of products 13 from 15 (and also from
3-unsubstituted indoles 14) is not trivial, since the previously
reported gold-catalyzed reaction of 15a with aldehydes as elec-
trophiles resulted in the divergent formation of 11H-indolo[3,2-
Beilstein J. Org. Chem. 2018, 14, 2411–2417.
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Table 2: Synthesis of 12-unsubstituted indolo[1,2-c]-quinazolines 13.a
Entry R1 R2 R3 14 Time (h) 13 (% yield)b
1 H H H 14a 5 13a (86)
2 Me H Me 14b 24 13b (87)
3 COOMe H COOMe 14c 6 13c (81)
4 H H Me 14d 25 13d (95)
5 Me Me H 14e 24 13e (73)
aReactions were carried out at 100 °C on 0.481 mmol scale using 1.2 equiv of DMFDMA in DMF (2 mL). bIsolated yields.
Scheme 4: Synthesis of indoles 14.
Scheme 5: Sequential preparation of 13a from 15a.
c]quinolines 17 (Scheme 5b) [32] through functionalization of
C-3 position of the indole ring instead of N-1.
The sequential reaction shown in Scheme 5, path a, probably
occurs through cyclization of 15a to indole 14a, followed by the
reaction with DMFDMA; however, an alternative path in which
one amino group interact with DMFDMA to give a formami-
dine intermediate [27] before cyclization cannot be ruled out.
Conclusion
We have reported here an efficient procedure for the prepara-
tion of 12-arylindolo[1,2-c]quinazolines 10 from o-(o-amino-
Beilstein J. Org. Chem. 2018, 14, 2411–2417.
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phenylethynyl) trifluoroacetanilides 5 and arylboronic acids, by
avoiding the isolation of intermediate indoles 9. Starting from
indoles 14, or from o-(o-aminophenylethynyl)aniline 15a, selec-
tive formation of 12-unsubstituted[1,2-c]quinazolines 13 was
accomplished, without competitive formation of products
derived from C-3 functionalization at the indole moiety.
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